Vistas y estadísticas descargadas: Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC
Mapa geográfico
| Región | Cantidad |
|---|---|
| AS - Asia, otros | 185 |
| NA - América del Norte | 106 |
| EU - Europa | 97 |
| AF - Africa | 9 |
| SA - América del Sur | 6 |
| OC - Oceanía | 3 |
| Total | 406 |
| País | Cantidad |
|---|---|
| CN - China | 129 |
| US - Estados Unidos de América | 98 |
| FR - Francia | 27 |
| IT - Italia | 14 |
| GB - Reino Unido | 13 |
| ES - España | 10 |
| NL - Holanda | 10 |
| HK - Hong Kong | 9 |
| JP - Japón | 9 |
| KR - Corea | 8 |
| other - Otro País | 79 |
| Total | 406 |
| Ciudad | Cantidad |
|---|---|
| Ashburn | 14 |
| Guangzhou | 11 |
| Paris | 11 |
| Hangzhou | 8 |
| Amsterdam | 7 |
| Chongqing | 7 |
| London | 6 |
| Hong Kong | 5 |
| Los Angeles | 5 |
| Nanjing | 4 |
| other | 265 |
| Total | 343 |
| Nombre del archivo | Cantidad |
|---|---|
| 195971 - Atezolizumab_First-Line.pdf - ITEM:( 10553/41871) | 406 |
| Total | 406 |
| Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Tot | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 13 | 18 | 11 | 50 |
| 2023 | 23 | 13 | 18 | 14 | 9 | 18 | 18 | 16 | 13 | 0 | 6 | 5 | 153 |
| 2024 | 4 | 10 | 14 | 6 | 19 | 14 | 16 | 12 | 10 | 12 | 22 | 23 | 162 |
| 2025 | 23 | 16 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41 |
| TOTAL | 406 | ||||||||||||